BioSpace News Archive

Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women’s health and prostate cancer, today announced the cancellation of its presentation and webcast at the Barclays Global Healthcare Conference, previously scheduled to take place on Wednesday, March 11 at 10:15 a.m. Eastern time. This follows the announcement by the organizer to cancel the in-person aspects of the conference due to circum

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced that Alison Lawton, President and Chief Executive Officer, will present during Chardan’s 2 nd Annual Microbiome Medicines Summit, a virtual event, on Monday, March 16, 2020 at 4:15 p.m. ET. A webcast of the presentation can be accessed o

Fluidigm Corporation announced the introduction of the AccuLift™ Laser Capture Microdissection System.

Amyris, Inc. announced that management will be participating in a fireside chat at the 32nd Annual Roth Conference to be held March 15-17, 2020, at the Ritz-Carlton, in Dana Point, California.

Attrax Putty is now the first and only ceramic bone graft substitute supported by Level I evidence to demonstrate non-inferior fusion performance compared to autograft(1)

Cancer patients in Bay County area now have access to multispecialty comprehensive cancer care at the Hope Regional Cancer Center, which it announced that it is the ONLY Cancer Center in Bay County to offer imaging services, chemotherapy infusion, radiation therapy and urological services under one roof.

Advarra, the premier provider of institutional review board, institutional biosafety committee, research quality and compliance consulting services, and standards-based research technology solutions from Forte, now part of Advarra, has announced the cancellation of its 2020 Spring Onsemble Conference for clinical research operations, scheduled for March 16-19.

Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute.

CVS Pharmacy, Inc., a subsidiary of CVS Health Corporation, and Schnucks announced that they have entered into a definitive agreement for CVS Pharmacy and certain of its subsidiaries to acquire Schnuck Markets Inc.'s retail and specialty pharmacy businesses.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced the underwriters of its previously announced public offering of common stock have fully exercised their over-allotment option resulting in the issuance of an additional 635,294 shares of common stock. The option was granted in connection with the public offering of 4,235,